Patent classifications
C07D211/94
THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
The invention provides a compound of formula (I): or a salt thereof, wherein A, B, R.sup.1, R.sup.2, R.sup.3 and X have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as therapeutic agents for treating diastolic dysfunction.
##STR00001##
THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
The invention provides a compound of formula (I): or a salt thereof, wherein A, B, R.sup.1, R.sup.2, R.sup.3 and X have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as therapeutic agents for treating diastolic dysfunction.
##STR00001##
STABILIZATION OF THERMOSET COMPOSITES AND COATING WITH A UV STABILIZING TECHNOLOGY AND TECHNIQUE FOR PRODUCING SAME
A reaction scheme to synthesize high functional UVS molecules such as 1,2,2,6,6-pentamethylpiperidin-4-yl methacrylate and use 1,2,2,6,6-pentamethylpiperidin-4-yl methacrylate for improved UV stability of a product using UVS additives.
BROMODOMAIN INHIBITORS
The present invention relates to substituted heterocyclic derivative compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition of acetyl lysine regions of proteins, such as histones. Said compositions and methods are useful for the treatment of cancer and neoplastic disease.
BROMODOMAIN INHIBITORS
The present invention relates to substituted heterocyclic derivative compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition of acetyl lysine regions of proteins, such as histones. Said compositions and methods are useful for the treatment of cancer and neoplastic disease.
TARGETED NITROXIDE AGENTS
Provided herein are compositions and related methods useful for free radical scavenging, with particular selectivity for mitochondria. The compounds comprise a nitroxide-containing group attached to a mitochondria-targeting group. The compounds can be cross-linked into dimers without loss of activity. Also provided herein are methods, for preventing, mitigating and treating damage caused by radiation. The method comprises delivering a compound, as described herein, to a patient in an amount and dosage regimen effective to prevent, mitigate or treat damage caused by radiation.
TARGETED NITROXIDE AGENTS
Provided herein are compositions and related methods useful for free radical scavenging, with particular selectivity for mitochondria. The compounds comprise a nitroxide-containing group attached to a mitochondria-targeting group. The compounds can be cross-linked into dimers without loss of activity. Also provided herein are methods, for preventing, mitigating and treating damage caused by radiation. The method comprises delivering a compound, as described herein, to a patient in an amount and dosage regimen effective to prevent, mitigate or treat damage caused by radiation.
ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY
The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials.
ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY
The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials.
Polymerisable compounds and the use thereof in liquid-crystal displays
The present invention relates to polymerisable compounds, to processes and intermediates for the preparation thereof, to liquid-crystal (LC) media comprising them, and to the use of the polymerisable compounds and LC media for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the polymer sustained alignment (PS, PSA) and self-aligning (SA) type.